{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:22:48Z","timestamp":1761060168009},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13023-016-0479-y","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T15:29:41Z","timestamp":1469201381000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities"],"prefix":"10.1186","volume":"11","author":[{"given":"Brigitte","family":"Gilbert-Dussardier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Briand-Suleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Laurendeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Bilan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Cav\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Verloes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Vidaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Vidaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Pasmant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,22]]},"reference":[{"key":"479_CR1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nm0306-283","volume":"12","author":"M Bentires-Alj","year":"2006","unstructured":"Bentires-Alj M, Kontaridis MI, Neel BG. Stops along the RAS pathway in human genetic disease. Nat Med. 2006;12:283\u20135.","journal-title":"Nat Med"},{"key":"479_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","volume":"7","author":"S Schubbert","year":"2007","unstructured":"Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 2007;7:295\u2013308.","journal-title":"Nat Rev Cancer"},{"key":"479_CR3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","volume":"19","author":"WE Tidyman","year":"2009","unstructured":"Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation. Curr Opin Genet Dev. 2009;19:230\u20136.","journal-title":"Curr Opin Genet Dev"},{"key":"479_CR4","doi-asserted-by":"crossref","first-page":"E1506","DOI":"10.1002\/humu.21271","volume":"31","author":"E Pasmant","year":"2010","unstructured":"Pasmant E, Sabbagh A, Spurlock G, et al. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat. 2010;31:E1506\u201318.","journal-title":"Hum Mutat"},{"key":"479_CR5","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/ajmg.a.37155","volume":"167A","author":"C Lissewski","year":"2015","unstructured":"Lissewski C, Kant SG, Stark Z, Schanze I, Zenker M. Copy number variants including RAS pathway genes-How much RASopathy is in the phenotype? Am J Med Genet A. 2015;167A:2685\u201390.","journal-title":"Am J Med Genet A"},{"key":"479_CR6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ajmg.a.32215","volume":"146A","author":"OA Shchelochkov","year":"2008","unstructured":"Shchelochkov OA, Patel A, Weissenberger GM, et al. Duplication of chromosome band 12q24.11q24.23 results in apparent Noonan syndrome. Am J Med Genet A. 2008;146A:1042\u20138.","journal-title":"Am J Med Genet A"},{"key":"479_CR7","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/ajmg.a.32992","volume":"149A","author":"JM Graham Jr","year":"2009","unstructured":"Graham Jr JM, Kramer N, Bejjani BA, et al. Genomic duplication of PTPN11 is an uncommon cause of Noonan syndrome. Am J Med Genet A. 2009;149A:2122\u20138.","journal-title":"Am J Med Genet A"},{"key":"479_CR8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/cge.12116","volume":"85","author":"MJ Nowaczyk","year":"2014","unstructured":"Nowaczyk MJ, Thompson BA, Zeesman S, et al. Deletion of MAP2K2\/MEK2: a novel mechanism for a RASopathy? Clin Genet. 2014;85:138\u201346.","journal-title":"Clin Genet"},{"key":"479_CR9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/jmg.2007.050450","volume":"44","author":"C Nava","year":"2007","unstructured":"Nava C, Hanna N, Michot C, et al. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS\/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet. 2007;44:763\u201371.","journal-title":"J Med Genet"},{"key":"479_CR10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ejhg.2014.145","volume":"23","author":"E Pasmant","year":"2015","unstructured":"Pasmant E, Parfait B, Luscan A, et al. Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations? Eur J Hum Genet. 2015;23:596\u2013601.","journal-title":"Eur J Hum Genet"},{"key":"479_CR11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2353\/jmoldx.2009.090064","volume":"11","author":"E Pasmant","year":"2009","unstructured":"Pasmant E, Sabbagh A, Masliah-Planchon J, et al. Detection and characterization of NF1 microdeletions by custom high resolution array CGH. J Mol Diagn. 2009;11:524\u20139.","journal-title":"J Mol Diagn"},{"key":"479_CR12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","volume":"38","author":"S Schubbert","year":"2006","unstructured":"Schubbert S, Zenker M, Rowe SL, et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006;38:331\u20136.","journal-title":"Nat Genet"},{"key":"479_CR13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0010049","volume":"1","author":"JR Lupski","year":"2005","unstructured":"Lupski JR, Stankiewicz P. Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet. 2005;1, e49.","journal-title":"PLoS Genet"},{"key":"479_CR14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","volume":"14","author":"KA Rauen","year":"2013","unstructured":"Rauen KA. The RASopathies. Annu Rev Genomics Hum Genet. 2013;14:355\u201369.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"479_CR15","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/jid.2011.67","volume":"131","author":"M Picardo","year":"2011","unstructured":"Picardo M, Cardinali G. The genetic determination of skin pigmentation: KITLG and the KITLG\/c-Kit pathway as key players in the onset of human familial pigmentary diseases. J Invest Dermatol. 2011;131:1182\u20135.","journal-title":"J Invest Dermatol"},{"key":"479_CR16","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ng2113","volume":"39","author":"H Brems","year":"2007","unstructured":"Brems H, Chmara M, Sahbatou M, et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet. 2007;39:1120\u20136.","journal-title":"Nat Genet"},{"key":"479_CR17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","volume":"105","author":"K DeBella","year":"2000","unstructured":"DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105:608\u201314.","journal-title":"Pediatrics"},{"key":"479_CR18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2008.065243","volume":"46","author":"E Pasmant","year":"2009","unstructured":"Pasmant E, Sabbagh A, Hanna N, et al. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet. 2009;46:425\u201330.","journal-title":"J Med Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-016-0479-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T19:01:23Z","timestamp":1498330883000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-016-0479-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,22]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1186\/s13023-016-0479-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,22]]},"article-number":"101"}}